A Review of the Current State of Nanomedicines for Targeting and Treatment of Cancers: Achievements and Future Challenges
Journal article
Authors | Ali Kermanizadeh, Nicklas Raun Jacobsen, Fiona Murphy, Leagh Powell, Lee Parry, Haiyuan Zhang and Peter Møller |
---|---|
Abstract | The design and utilization of nanomedicines offers great potential for treating various diseases including cancers. Current challenges with traditional cancer treatment strategies include but are not limited to lack of specific targeting, overt systemic toxicity and low efficacy. The use of nanomaterials show particular promise as candidates for cancer treatment due to their high surface to volume ratio and tuneable size, shape, and surface chemistry, which in combination, allow for improved tumor targeting and enhanced therapeutic efficacy. The scrutinization of the literature demonstrates the potential of nanosized carrier systems over traditional approaches (at the molecular level) for specific targeting of the tumors. Despite the great promise showing in preclinical studies, the number of nanomedicines reaching clinical testing is still very low. This review attempts to address this issue by using a weight of evidence approach to the different strategies for use of nanomedicines in combating cancer, as well as highlighting a number of areas that the field of nanomedicines is clearly lagging behind in, as compared to conventional drug discovery and development. It is hoped that the recommendations in this review will allow for better translation of nanomedicines reaching clinical trials. |
Keywords | cancer; inappropriate test models; nanomedicines; oncological nanomedicines; targeting and therapy |
Year | 2020 |
Journal | Advanced Therapeutics |
Journal citation | Vol 4 (Issue 2, Article: 2000186) |
Publisher | John Wiley & Sons Ltd |
ISSN | 23663987 |
Digital Object Identifier (DOI) | https://doi.org/10.1002/adtp.202000186 |
Web address (URL) | https://doi.org/10.1002/adtp.202000186 |
Output status | Published |
Publication dates | 09 Feb 2021 |
Online | 09 Nov 2020 |
Publication process dates | |
Deposited | 12 Jun 2023 |
https://repository.derby.ac.uk/item/9z33y/a-review-of-the-current-state-of-nanomedicines-for-targeting-and-treatment-of-cancers-achievements-and-future-challenges
35
total views0
total downloads1
views this month0
downloads this month
Export as
Related outputs
A comprehensive toxicological analysis of panel of unregulated e-cigarettes to human health
Guraka, A., Mierlea, S., Drake, S., Shawa, T. S., Waldron, S., Corcoran, M., Dowse, D., Walkman, D., Burn, L., Sivasubramaniam, S. and Kermanizadeh, A. 2024. A comprehensive toxicological analysis of panel of unregulated e-cigarettes to human health. Toxicology. 509, pp. 1-12. https://doi.org/10.1016/j.tox.2024.153964A Review of Toxicological Profile of Fentanyl—A 2024 Update
Kermanizadeh, A. and Williamson, J. 2024. A Review of Toxicological Profile of Fentanyl—A 2024 Update. Toxics. 12 (10), pp. 1-14. https://doi.org/10.3390/toxics12100690Co-Culture of Gut Bacteria and Metabolite Extraction Using Fast Vacuum Filtration and Centrifugation
Guraka, A., Duff, R., Waldron, J., Tripathi, G. and Kermanizadeh, A. 2024. Co-Culture of Gut Bacteria and Metabolite Extraction Using Fast Vacuum Filtration and Centrifugation. Methods and Protocols. 7 (74), pp. 1-13. https://doi.org/10.3390/mps7050074Microplastic-induced hepatic adverse effects evaluated in advanced quadruple cell human primary models following three weeks of repeated exposure
Guraka, A., Souch, G., Duff, R., Brown, D., Moritz, W. and Ali Kermanizadeh 2024. Microplastic-induced hepatic adverse effects evaluated in advanced quadruple cell human primary models following three weeks of repeated exposure. Chemosphere. pp. 1-36. https://doi.org/10.1016/j.chemosphere.2024.143032Next Generation Risk Assessment approaches for advanced nanomaterials: Current status and future perspectives
Hristozov, D., Badetti, E., Bigini, P., Brunelli, A., Dekkers, S., Diomede, L., Doak, S. K., Fransman, W., Gajewicz-Skretna, A., Giubilato, E., Gómez-Cuadrado, L., Grafström, R., Gutleb, R. C., Halappanavar, S., Hischier, R., Hunt, N., Katsumiti, A., Kermanizadeh, A., Marcomini, A., Moschini, E., Oomen, E., Pizzol, L., Rumbo, C., Schmid, O., Shandilya, N., Stone, V., Stoycheva, S, Stoeger, T., Merino, B. S., Tran, L., Tsiliki, G., Vogel, U. B., Wohlleben, W. and Zabeo, A. 2024. Next Generation Risk Assessment approaches for advanced nanomaterials: Current status and future perspectives. NanoImpact. pp. 1-48. https://doi.org/10.1016/j.impact.2024.100523Drug induced liver injury - a 2023 update.
Allison, R., Guraka, A., Shawa, I., Tripathi, G., Moritz, W. and Kermanizadeh, A. 2023. Drug induced liver injury - a 2023 update. Journal of Toxicology and Environmental Health, Part B. 26 (8), pp. 1-26. https://doi.org/10.1080/10937404.2023.2261848AIMS: An Automatic Semantic Machine Learning Microservice Framework to Support Biomedical and Bioengineering Research
Yu, H., O'Neill, S. and Kermanizadeh, A. 2023. AIMS: An Automatic Semantic Machine Learning Microservice Framework to Support Biomedical and Bioengineering Research. Bioengineering. 10 (10), pp. 1-18. https://doi.org/10.3390/bioengineering10101134